The bulk of the terminated grants have to do with vaccine hesitancy, HIV, Black or Latino communities and/or sex, gender and ...
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RH ("RH" or "the Company") (NYSE:RH). Investors ...
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XPEL, Inc. ("XPEL" or "the Company") (NASDAQ:XPEL). Investors who purchased XPEL securities prior to ...
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pliant Therapeutics, Inc. ("Pliant" or "the Company") (NASDAQ:PLRX). Investors who purchased Pliant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results